ZA201209745B - Compositions containing flavones and anthelmintics - Google Patents
Compositions containing flavones and anthelminticsInfo
- Publication number
- ZA201209745B ZA201209745B ZA2012/09745A ZA201209745A ZA201209745B ZA 201209745 B ZA201209745 B ZA 201209745B ZA 2012/09745 A ZA2012/09745 A ZA 2012/09745A ZA 201209745 A ZA201209745 A ZA 201209745A ZA 201209745 B ZA201209745 B ZA 201209745B
- Authority
- ZA
- South Africa
- Prior art keywords
- anthelmintics
- compositions containing
- containing flavones
- flavones
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1054881A FR2961399A1 (en) | 2010-06-18 | 2010-06-18 | COMPOSITIONS BASED ON FLAVONES AND ANTHELMINTHICS |
PCT/FR2011/051334 WO2011157936A1 (en) | 2010-06-18 | 2011-06-10 | Compositions containing flavones and anthelmintics |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA201209745B true ZA201209745B (en) | 2014-03-26 |
Family
ID=42668745
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA2012/09745A ZA201209745B (en) | 2010-06-18 | 2012-12-21 | Compositions containing flavones and anthelmintics |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP2582370A1 (en) |
AU (1) | AU2011266864C1 (en) |
FR (1) | FR2961399A1 (en) |
NZ (1) | NZ605982A (en) |
WO (1) | WO2011157936A1 (en) |
ZA (1) | ZA201209745B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110810415B (en) * | 2019-11-29 | 2021-06-15 | 北京农学院 | Application of kaempferol 3, 4' -diglycoside 7-rhamnoside |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2375647A1 (en) * | 1999-07-08 | 2001-01-18 | Patrick T. Prendergast | Use of flavones, coumarins and related compounds to treat infections |
WO2002069949A2 (en) * | 2001-03-06 | 2002-09-12 | Prendergast Patrick T | Combination therapy for reduction of toxycity of chemotherapeutic agents |
JP2009537630A (en) * | 2006-05-19 | 2009-10-29 | ザ ホンコン ポリテクニック ユニヴァーシティー | Flavonoid dimers and methods for their production and use |
WO2008085995A1 (en) * | 2007-01-09 | 2008-07-17 | Merck & Co., Inc. | Anthelmintic flavones from struthiola argenta |
US20090082400A1 (en) | 2007-07-31 | 2009-03-26 | Ving Lee | Soluble pyrone analogs methods and compositions |
-
2010
- 2010-06-18 FR FR1054881A patent/FR2961399A1/en not_active Withdrawn
-
2011
- 2011-06-10 EP EP11735482.9A patent/EP2582370A1/en not_active Withdrawn
- 2011-06-10 WO PCT/FR2011/051334 patent/WO2011157936A1/en active Application Filing
- 2011-06-10 NZ NZ605982A patent/NZ605982A/en not_active IP Right Cessation
- 2011-06-10 AU AU2011266864A patent/AU2011266864C1/en not_active Ceased
-
2012
- 2012-12-21 ZA ZA2012/09745A patent/ZA201209745B/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP2582370A1 (en) | 2013-04-24 |
WO2011157936A1 (en) | 2011-12-22 |
AU2011266864C1 (en) | 2016-06-02 |
AU2011266864A1 (en) | 2013-01-10 |
AU2011266864B2 (en) | 2016-02-18 |
NZ605982A (en) | 2015-02-27 |
FR2961399A1 (en) | 2011-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL253870B (en) | Certain amino-pyrimidines and pharmaceutical compositions comprising them | |
ZA201209259B (en) | Uses and compositions | |
AP3106A (en) | Antiparisitic dihydroazole compounds and compositions comprising same | |
EP2646468A4 (en) | Anti-ngf compositions and use thereof | |
EP2446031A4 (en) | Stabilizing alkylglycoside compositions and methods thereof | |
IL223153A0 (en) | Compositions comprising acid and derivatives thereof and uses thereof | |
GB201006096D0 (en) | Novel compositions and uses thereof | |
PL2579839T3 (en) | Perfuming compositions and uses thereof | |
EP2629742A4 (en) | Hair-mending compositions and associated methods | |
PL2605757T3 (en) | Nalbuphine-based formulations and uses thereof | |
GB201015132D0 (en) | Vaccine composition | |
EP2588117A4 (en) | Stable antiseptic compositions and methods | |
HK1178072A1 (en) | Veterinary compositions | |
HK1213594A1 (en) | Immunogenic compositions and uses thereof | |
GB201005625D0 (en) | Immunogenic proteins and compositions | |
PL2624836T3 (en) | Bepotastine compositions | |
ZA201301608B (en) | Compositions comprising oleuropeins and flavanoids and their use | |
GB201103423D0 (en) | Immunogenic proteins and compositions | |
EP2627391A4 (en) | Hydrophobic catheter and composition | |
EP2609931A4 (en) | Immunogenic composition | |
EP2874641A4 (en) | Glutathione-elevating compositions and uses thereof | |
HK1201451A1 (en) | Compositions and methods | |
GB201018650D0 (en) | Methods and compositions | |
IL226554A (en) | Pharmaceutical compositions comprising alisporivir | |
IL221087A (en) | Pharmaceutical or neutraceutical formulation |